Compare AXT Inc (AXTI) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AXT Inc vs GSK plc — how do they compare? AXT Inc trades at $78.71 (market cap $4.83B), while GSK plc trades at $50.5 (market cap $102.60B). The key difference: GSK plc is far larger — about 21.2× AXT Inc's market cap, and GSK plc pays a 3.57% dividend while AXT Inc pays none. Which is the better fit depends on your goals.
| AXTI | GSK | |
|---|---|---|
Market Cap | $4.83B | $102.60B |
Sector | Technology | Health |
52-Week High | $140.83 | $61.18 |
52-Week Low | $2.05 | $38.22 |
Enterprise Value | $4.50B | $123.04B |
Dividend Yield | — | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
